ELCC 2019: European Lung Cancer Congress

Maintenance immunotherapy did not improve survival in patients with extensive-stage small cell lung cancer (SCLC), according to late-breaking results from the CheckMate 451 study presented today by Ow...

lung cancer

issues in oncology

immunotherapy

By The ASCO Post Staff / ELCC 2019: European Lung Cancer Congress

ELCC 2019: Immunotherapy in Elderly Patients With Advanced NSCLC

Two studies reported at the European Lung Cancer Congress (ELCC) 2019 provided new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non–small cell lung...

ELCC 2019: European Lung Cancer Congress

ELCC 2019: Does Maintenance Immunotherapy Improve Survival in Patients With Advanced SCLC?

ELCC 2019: Immunotherapy in Elderly Patients With Advanced NSCLC

FDA Approves Lu-177 Dotatate for Pediatric Patients With GEP-NETs

AI Model May Help Predict Treatment Responses Select Most Effective Cancer Therapies in Patients With Cancer

In-Hospital Mortality Among Patients With COVID-19 Infection, With or Without Cancer

Imaging Drug to Assist in Detection of Cancerous Tissue Following Lumpectomy Approved

Potential Protective Effects of Aspirin Against Colorectal Cancer